Fecal calprotectin in very low birth weight infants

Journal of Pediatric Gastroenterology and Nutrition

Volumn 44, Issue 4, 2007, Pages 407-413

  Josefsson, Stina ^a   Bunn, Susan K ^b   Domellöf, Magnus ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Fecal calprotectin; Infant; Necrotizing enterocolitis; Very low birth weight

Indexed keywords

ANTIBIOTIC AGENT; CALPROTECTIN; CORTICOSTEROID;

ABDOMINAL DISEASE; ARTICLE; BIRTH WEIGHT; CESAREAN SECTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DELIVERY; DISEASE SEVERITY; ENTERIC FEEDING; ENTERITIS; FECES ANALYSIS; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; INTESTINE PERFORATION; LAPAROTOMY; MAJOR CLINICAL STUDY; MALE; MECONIUM; NECROTIZING ENTEROCOLITIS; NEWBORN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN DETERMINATION; SAMPLING; VERY LOW BIRTH WEIGHT;

BIOLOGICAL MARKERS; ENTEROCOLITIS, NECROTIZING; FECES; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MECONIUM;

EID: 34147099101     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3180320643     Document Type: Article

References (26)

1. Kliegman RM. Neonatal necrotizing enterocolitis: bridging the basic science with the clinical disease. J Pediatr 1990;117:833-5.
2. Kliegman RM. Neonatal necrotizing enterocolitis. In: Wyllie R, Hyams JS (eds). Pediatric Gastrointestinal Disease. Philadelphia: WB Saunders; 1999. pp. 455-65.
3. Kliegman RM. Models of the pathogenesis of necrotizing enterocolitis. J Pediatr 1990;117 (Suppl):S2-5.
4. Hwang H, Murphy JJ, Gow KW, et al. Are localized intestinal perforations distinct from necrotizing enterocolitis? J Pediatr Surg 2003;38:763-7.
5. Musemeche C, Caplan M, Hsueh W, et al. Experimental necrotizing enterocolitis: the role of polymorphonuclear neutrophils. J Pediatr Surg 1991;26:1047-9.
6. Dale I, Brandtzaeg P, Fagerhol MK, et al. Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leukocytes: immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin. Am J Clin Pathol 1985;84:24-34.
7. Johne B, Fagerhol MK, Lyberg T, et al. Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol Pathol 1997;50:113-23.
8. Roseth AG, Fagerhol MK, Aadland E, et al. Assessment of the neutrophil dominating protein calprotectin in feces: a methodologic study. Scand J Gastroenterol 1992;27:793-8.
9. Tøn H, Brandsnes O, Dale S, et al. Improved assay for fecal calprotectin. Clin Chim Acta 2000;292:41-54.
10. Berstad A, Arslan G, Folvik G. Relationship between intestinal permeability and calprotectin concentration in gut lavage fluid. Scand J Gastroenterol 2000;35:64-9.
11. Roseth AG, Aadland E, Jahnsen J, et al. Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion 1997;58:176-80.
12. Bunn SK, Bisset WM, Main MJ, et al. Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2001;32:171-7.
13. Olafsdottir E, Aksnes L, Fluge G, et al. Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children. Acta Paediatr 2002;91:45-50.
14. Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis: therapeutic decisions based upon clinical staging. Ann Surg 1978;187:1-7.
15. Rugtveit J, Fagerhol MK. Age-dependent variations in fecal calprotectin concentrations in children. J Pediatr Gastroenterol Nutr 2002;34:323-4.
16. Nissen AC, van Gils CE, Menheere PP, et al. Fecal calprotectin in healthy term and preterm infants. J Pediatr Gastroenterol Nutr 2004;38:107-8.
17. Weaver LT, Laker MF, Nelson R. Intestinal permeability in the newborn. Arch Dis Child 1984;59:236-41.
18. Cummins AG, Thompson FM. Postnatal changes in mucosal immune response: a physiological perspective of breast feeding and weaning. Immunol Cell Biol 1997;75:419-29.
19. Laforgia N, Baldassarre ME, Pontrelli G, et al. Calprotectin levels in meconium. Acta Paediatr 2003;92:463-6.
20. Campeotto F, Butel MJ, Kalach N, et al. High faecal calprotectin concentrations in newborn infants. Arch Dis Child Fetal Neonatal Ed 2004;89:F353-5.
21. Long SS, Swenson RM. Development of anaerobic fecal flora in healthy newborn infants. J Pediatr 1977;91:298-301.
22. Gronlund MM, Lehtonen OP, Eerola E, et al. Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery. J Pediatr Gastroenterol Nutr 1999;28:19-25.
23. Amer MD, Hedlund E, Rochester J, et al. Platelet-activating factor concentration in the stool of human newborns: effects of enteral feeding and neonatal necrotizing enterocolitis. Biol Neonate 2004;85:159-66.
24. Cummins AG, Eglinton BA, Gonzalez A, et al. Immune activation during infancy in healthy humans. J Clin Immunol 1994;14:107-15.
25. Carroll D, Corfield A, Spicer R, et al. Faecal calprotectin concentrations and diagnosis of necrotising enterocolitis. Lancet 2003;361:310-1.
26. Tam AL, Camberos A, Applebaum H. Surgical decision making in necrotizing enterocolitis and focal intestinal perforation: predictive value of radiologic findings. J Pediatr Surg 2002;37: 1688-91.